Economic portfolio
Bandhan BSE Healthcare Index Fund
BANDHAN Bandhan Mutual Fund Sep 2024 — Sep 2026 25 months
Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →
Days to sell half: 0.0 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
How concentrated it has been
25 priced months, Sep 2024 to Sep 2026 · at each month’s NSE closes
Top 10 holdings, share of equity
53.2% now, 55.2% in Sep 2025 · highest 58.9%, lowest 53.2%
Companies held
138 now, 119 in Sep 2025 · largest single holding 12.3% of equity
How it trades: no clear lean toward recent winners or losers (score +0.03 over 24 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- Motilal Oswal BSE Healthcare ETFMotilal Oswal · 137 shared100.0%
- Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 44 shared85.2%
- EODWHFEdelweiss · 25 shared74.1%
- DSP Nifty Healthcare ETFDSP · 20 shared70.3%
- ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETFAditya Birla Sun Life · 20 shared70.3%
- Axis NIFTY Healthcare ETFAxis · 20 shared70.3%
- ICICI Prudential Nifty Healthcare ETFICICI Prudential · 20 shared70.3%
- DSP Nifty Healthcare Index FundDSP · 20 shared70.3%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
What changed in Sep 2026
This portfolio’s consecutive disclosures · evidenced adjustments applied
New positions
- 01 Anlon Healthcare Limited +3,281
- 02 Shukra Pharmaceuticals Limited +2,830
- 03 Gennex Laboratories Ltd +2,271
- 04 TAKE Limited +1,943
- 05 Ambalal Sarabhai Enterprise Ltd. +664
- 06 Ind-Swift Laboratories Limited +640
- 07 Medico Remedies Limited +425
- 08 Gaudium IVF and Women Health Limited +277
- 09 Amrutanjan Health Care Limited +200
- 10 Sai Parenterals Limited +157
Complete exits
Largest increases
- 01 Rubicon Research Limited+115.3% +466
- 02 Krishna Institute of Medical Sciences Limited+8.7% +279
- 03 Sun Pharmaceutical Industries Limited+1.9% +268
- 04 Park Medi World Limited+33.3% +241
- 05 Nephrocare Health Services Limited+67.6% +192
- 06 Max Healthcare Institute Limited+1.9% +184
- 07 CORONA Remedies Limited+215.2% +170
- 08 Laurus Labs Limited+3.4% +170
- 09 Piramal Pharma Limited+2.1% +168
- 10 Dr. Reddy's Laboratories Limited+1.9% +151
Largest reductions
Share quantities, not market values or cash flows.
Holdings by value
Sep 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Healthcare | Large Cap | 12.32% | 2.58 Cr | 14,182 | by Sep 2024 (25 mo+) |
| Divi's Laboratories Limited | Healthcare | Large Cap | 7.44% | 1.56 Cr | 1,674 | by Sep 2024 (25 mo+) |
| Apollo Hospitals Enterprise Limited | Healthcare | Large Cap | 5.24% | 1.09 Cr | 1,341 | by Sep 2024 (25 mo+) |
| Laurus Labs Limited | Healthcare | Mid Cap | 4.84% | 1.01 Cr | 5,110 | by Sep 2024 (25 mo+) |
| Cipla Limited | Healthcare | Large Cap | 4.78% | 1.00 Cr | 7,428 | by Sep 2024 (25 mo+) |
| Dr. Reddy's Laboratories Limited | Healthcare | Large Cap | 4.72% | 0.99 Cr | 8,003 | by Sep 2024 (25 mo+) |
| Max Healthcare Institute Limited | Healthcare | Large Cap | 4.32% | 0.90 Cr | 9,716 | by Sep 2024 (25 mo+) |
| Torrent Pharmaceuticals Limited | Healthcare | Large Cap | 3.56% | 0.74 Cr | 1,549 | by Sep 2024 (25 mo+) |
| Lupin Limited | Healthcare | Mid Cap | 3.09% | 0.65 Cr | 3,183 | by Sep 2024 (25 mo+) |
| Aurobindo Pharma Limited | Healthcare | Mid Cap | 2.90% | 0.61 Cr | 3,628 | by Sep 2024 (25 mo+) |
| Fortis Healthcare Limited | Healthcare | Mid Cap | 2.52% | 0.53 Cr | 6,843 | by Sep 2024 (25 mo+) |
| Glenmark Pharmaceuticals Limited | Healthcare | Mid Cap | 2.19% | 0.46 Cr | 1,965 | by Sep 2024 (25 mo+) |
| Alkem Laboratories Limited | Healthcare | Mid Cap | 1.90% | 0.40 Cr | 770 | by Sep 2024 (25 mo+) |
| Zydus Lifesciences Limited | Healthcare | Mid Cap | 1.82% | 0.38 Cr | 3,276 | by Sep 2024 (25 mo+) |
| Mankind Pharma Limited | Healthcare | Mid Cap | 1.75% | 0.37 Cr | 1,465 | by Sep 2024 (25 mo+) |
| IPCA Laboratories Limited | Healthcare | Mid Cap | 1.69% | 0.35 Cr | 1,833 | by Sep 2024 (25 mo+) |
| Biocon Limited | Healthcare | Mid Cap | 1.63% | 0.34 Cr | 9,205 | by Sep 2024 (25 mo+) |
| Gland Pharma Limited | Healthcare | Small Cap | 1.44% | 0.30 Cr | 1,040 | by Sep 2024 (25 mo+) |
| Sai Life Sciences Limited | Healthcare | Small Cap | 1.30% | 0.27 Cr | 1,785 | Mar 2025 (19 mo) |
| Krishna Institute of Medical Sciences Limited | Healthcare | Small Cap | 1.24% | 0.26 Cr | 3,476 | by Sep 2024 (25 mo+) |
| Aster DM Quality Care Limited | Healthcare | Small Cap | 1.18% | 0.25 Cr | 3,549 | by Sep 2024 (25 mo+) |
| Neuland Laboratories Limited | Healthcare | Small Cap | 1.15% | 0.24 Cr | 113 | by Sep 2024 (25 mo+) |
| Wockhardt Limited | Healthcare | Small Cap | 1.10% | 0.23 Cr | 1,089 | by Sep 2024 (25 mo+) |
| Acutaas Chemicals Limited | Healthcare | Small Cap | 1.06% | 0.22 Cr | 678 | by Sep 2024 (25 mo+) |
| Ajanta Pharma Limited | Healthcare | Small Cap | 1.02% | 0.21 Cr | 591 | by Sep 2024 (25 mo+) |
| Dr. Lal Path Labs Ltd. | Healthcare | Small Cap | 0.96% | 0.20 Cr | 1,014 | by Sep 2024 (25 mo+) |
| Abbott India Limited | Healthcare | Mid Cap | 0.87% | 0.18 Cr | 67 | by Sep 2024 (25 mo+) |
| Piramal Pharma Limited | Healthcare | Small Cap | 0.81% | 0.17 Cr | 8,219 | by Sep 2024 (25 mo+) |
| Narayana Hrudayalaya Ltd. | Healthcare | Mid Cap | 0.78% | 0.16 Cr | 913 | by Sep 2024 (25 mo+) |
| Shilpa Medicare Limited | Healthcare | Small Cap | 0.77% | 0.16 Cr | 1,541 | by Sep 2024 (25 mo+) |
| Granules India Limited | Healthcare | Small Cap | 0.76% | 0.16 Cr | 1,888 | by Sep 2024 (25 mo+) |
| Global Health Limited | Healthcare | Mid Cap | 0.76% | 0.16 Cr | 1,165 | by Sep 2024 (25 mo+) |
| Onesource Specialty Pharma Limited | Healthcare | Small Cap | 0.75% | 0.16 Cr | 1,024 | Sep 2025 (13 mo) |
| GlaxoSmithKline Pharmaceuticals Limited | Healthcare | Mid Cap | 0.71% | 0.15 Cr | 534 | by Sep 2024 (25 mo+) |
| Rubicon Research Limited | Healthcare | Small Cap | 0.67% | 0.14 Cr | 870 | Mar 2026 (7 mo) |
| Anthem Biosciences Limited | Healthcare | Mid Cap | 0.58% | 0.12 Cr | 1,406 | Mar 2026 (7 mo) |
| Jubilant Pharmova Limited | Healthcare | Small Cap | 0.51% | 0.11 Cr | 1,046 | by Sep 2024 (25 mo+) |
| Emcure Pharmaceuticals Limited | Healthcare | Small Cap | 0.51% | 0.11 Cr | 548 | Mar 2025 (19 mo) |
| Strides Pharma Science Limited | Healthcare | Small Cap | 0.47% | 0.10 Cr | 872 | by Sep 2024 (25 mo+) |
| Natco Pharma Limited | Healthcare | Small Cap | 0.47% | 0.10 Cr | 1,176 | by Sep 2024 (25 mo+) |
| Cohance Lifesciences Limited | Healthcare | Small Cap | 0.45% | 0.09 Cr | 2,111 | by Sep 2024 (25 mo+) |
| Vijaya Diagnostic Centre Limited | Healthcare | Small Cap | 0.45% | 0.09 Cr | 649 | by Sep 2024 (25 mo+) |
| Syngene International Limited | Healthcare | Small Cap | 0.44% | 0.09 Cr | 2,492 | by Sep 2024 (25 mo+) |
| Marksans Pharma Limited | Healthcare | Small Cap | 0.43% | 0.09 Cr | 2,798 | by Sep 2024 (25 mo+) |
| Rainbow Childrens Medicare Limited | Healthcare | Small Cap | 0.42% | 0.09 Cr | 667 | by Sep 2024 (25 mo+) |
| Poly Medicure Limited | Healthcare | Small Cap | 0.39% | 0.08 Cr | 493 | by Sep 2024 (25 mo+) |
| Indegene Limited | Healthcare | Small Cap | 0.38% | 0.08 Cr | 1,361 | by Sep 2024 (25 mo+) |
| Eris Lifesciences Limited | Healthcare | Small Cap | 0.38% | 0.08 Cr | 674 | by Sep 2024 (25 mo+) |
| Pfizer Limited | Healthcare | Small Cap | 0.37% | 0.08 Cr | 198 | by Sep 2024 (25 mo+) |
| Metropolis Healthcare Limited | Healthcare | Small Cap | 0.36% | 0.08 Cr | 1,389 | by Sep 2024 (25 mo+) |
| Caplin Point Laboratories Limited | Healthcare | Small Cap | 0.34% | 0.07 Cr | 260 | by Sep 2024 (25 mo+) |
| Aarti Pharmalabs Limited | Healthcare | Small Cap | 0.31% | 0.06 Cr | 679 | by Sep 2024 (25 mo+) |
| Jupiter Life Line Hospitals Limited | Not classified | Small Cap | 0.30% | 0.06 Cr | 2,498 | by Sep 2024 (25 mo+) |
| Concord Biotech Limited | Healthcare | Small Cap | 0.29% | 0.06 Cr | 440 | by Sep 2024 (25 mo+) |
| Bliss GVS Pharma Limited | Not classified | Small Cap | 0.29% | 0.06 Cr | 865 | by Sep 2024 (25 mo+) |
| Alembic Pharmaceuticals Limited | Not classified | Small Cap | 0.29% | 0.06 Cr | 723 | by Sep 2024 (25 mo+) |
| Procter & Gamble Health Limited | Healthcare | Small Cap | 0.28% | 0.06 Cr | 105 | by Sep 2024 (25 mo+) |
| Yatharth Hospital & Trauma Care Services Limited | Healthcare | Small Cap | 0.28% | 0.06 Cr | 557 | by Sep 2024 (25 mo+) |
| Morepen Laboratories Limited | Not classified | Small Cap | 0.27% | 0.06 Cr | 4,535 | by Sep 2024 (25 mo+) |
| Alivus Life Sciences Limited | Not classified | Small Cap | 0.27% | 0.06 Cr | 403 | by Sep 2024 (25 mo+) |
| CORONA Remedies Limited | Not classified | Small Cap | 0.25% | 0.05 Cr | 249 | Mar 2026 (7 mo) |
| AstraZeneca Pharma India Limited | Not classified | Small Cap | 0.24% | 0.05 Cr | 82 | by Sep 2024 (25 mo+) |
| Viyash Scientific Limited | Healthcare | Small Cap | 0.23% | 0.05 Cr | 2,066 | by Sep 2024 (25 mo+) |
| Dr. Agarwal's Health Care Limited | Not classified | Small Cap | 0.23% | 0.05 Cr | 999 | Sep 2025 (13 mo) |
| Healthcare Global Enterprises Limited | Healthcare | Small Cap | 0.22% | 0.05 Cr | 686 | by Sep 2024 (25 mo+) |
| Senores Pharmaceuticals Limited | Healthcare | Small Cap | 0.22% | 0.05 Cr | 327 | Mar 2025 (19 mo) |
| Thyrocare Technologies Limited | Healthcare | Small Cap | 0.21% | 0.04 Cr | 815 | by Sep 2024 (25 mo+) |
| Akums Drugs and Pharmaceuticals Limited | Healthcare | Small Cap | 0.18% | 0.04 Cr | 455 | Mar 2025 (19 mo) |
| Sanofi India Limited | Not classified | Small Cap | 0.17% | 0.04 Cr | 118 | by Sep 2024 (25 mo+) |
| Kovai Medical Center & Hospital Limited | Not classified | Small Cap | 0.17% | 0.04 Cr | 60 | by Sep 2024 (25 mo+) |
| Sanofi Consumer Healthcare India Limited | Not classified | Small Cap | 0.16% | 0.03 Cr | 88 | Mar 2025 (19 mo) |
| Supriya Lifescience Limited | Healthcare | Small Cap | 0.15% | 0.03 Cr | 338 | by Sep 2024 (25 mo+) |
| Nephrocare Health Services Limited | Healthcare | Small Cap | 0.15% | 0.03 Cr | 476 | Mar 2026 (7 mo) |
| Suven Life Sciences Limited | Healthcare | Small Cap | 0.15% | 0.03 Cr | 971 | by Sep 2024 (25 mo+) |
| IOL Chemicals and Pharmaceuticals Limited | Not classified | Small Cap | 0.15% | 0.03 Cr | 1,465 | by Sep 2024 (25 mo+) |
| Blue Jet Healthcare Limited | Healthcare | Small Cap | 0.13% | 0.03 Cr | 497 | by Sep 2024 (25 mo+) |
| Park Medi World Limited | Healthcare | Small Cap | 0.13% | 0.03 Cr | 965 | Mar 2026 (7 mo) |
| Ind-Swift Laboratories Limited | Not classified | Small Cap | 0.12% | 0.02 Cr | 640 | Sep 2026 (1 mo) |
| Sun Pharma Advanced Research Company Limited | Healthcare | Small Cap | 0.12% | 0.02 Cr | 1,236 | by Sep 2024 (25 mo+) |
| Innova Captab Limited | Not classified | Small Cap | 0.12% | 0.02 Cr | 210 | by Sep 2024 (25 mo+) |
| Solara Active Pharma Sciences Limited | Not classified | Small Cap | 0.11% | 0.02 Cr | 320 | by Sep 2024 (25 mo+) |
| Artemis Medicare Services Limited | Not classified | Small Cap | 0.11% | 0.02 Cr | 644 | by Sep 2024 (25 mo+) |
| Kwality Pharmaceuticals Limited | Not classified | Small Cap | 0.10% | 0.02 Cr | 60 | Sep 2025 (13 mo) |
| FDC Limited | Not classified | Small Cap | 0.10% | 0.02 Cr | 642 | by Sep 2024 (25 mo+) |
| Indraprastha Medical Corporation Limited | Not classified | Small Cap | 0.10% | 0.02 Cr | 578 | by Sep 2024 (25 mo+) |
| Aarti Drugs Limited | Not classified | Small Cap | 0.10% | 0.02 Cr | 468 | by Sep 2024 (25 mo+) |
| Orchid Pharma Limited | Not classified | Small Cap | 0.10% | 0.02 Cr | 200 | by Sep 2024 (25 mo+) |
| SMS Pharmaceuticals Limited | Not classified | Small Cap | 0.09% | 0.02 Cr | 381 | by Sep 2024 (25 mo+) |
| Novartis India Limited | Not classified | Small Cap | 0.09% | 0.02 Cr | 94 | by Sep 2024 (25 mo+) |
| Venus Remedies Ltd. | Not classified | Small Cap | 0.09% | 0.02 Cr | 100 | Sep 2026 (1 mo) |
| Shukra Pharmaceuticals Limited | Not classified | Small Cap | 0.08% | 0.02 Cr | 2,830 | Sep 2026 (1 mo) |
| Advanced Enzyme Technologies Limited | Healthcare | Small Cap | 0.08% | 0.02 Cr | 618 | by Sep 2024 (25 mo+) |
| RPG Life Sciences Limited | Not classified | Small Cap | 0.08% | 0.02 Cr | 56 | by Sep 2024 (25 mo+) |
| Gujarat Themis Biosyn Limited | Not classified | Small Cap | 0.08% | 0.02 Cr | 415 | by Sep 2024 (25 mo+) |
| Gufic Biosciences Limited | Not classified | Small Cap | 0.07% | 0.02 Cr | 356 | by Sep 2024 (25 mo+) |
| Syncom Formulations (India) Limited | Not classified | Small Cap | 0.07% | 0.02 Cr | 6,050 | by Sep 2024 (25 mo+) |
| Unichem Laboratories Limited | Not classified | Small Cap | 0.07% | 0.01 Cr | 268 | by Sep 2024 (25 mo+) |
| Krsnaa Diagnostics Limited | Not classified | Small Cap | 0.06% | 0.01 Cr | 239 | by Sep 2024 (25 mo+) |
| Dishman Carbogen Amcis Limited | Not classified | Small Cap | 0.06% | 0.01 Cr | 844 | by Sep 2024 (25 mo+) |
| Fredun Pharmaceuticals Limited | Not classified | Small Cap | 0.06% | 0.01 Cr | 93 | Sep 2026 (1 mo) |
Half of its current holdings have been held for 25 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| Anlon Healthcare Limited | Sep 2026 | ▲ New position | +3,281 |
| Shukra Pharmaceuticals Limited | Sep 2026 | ▲ New position | +2,830 |
| Gennex Laboratories Ltd | Sep 2026 | ▲ New position | +2,271 |
| TAKE Limited | Sep 2026 | ▲ New position | +1,943 |
| Nectar Lifesciences Limited | Sep 2026 | ▼ Complete exit | -1,202 |
| Ambalal Sarabhai Enterprise Ltd. | Sep 2026 | ▲ New position | +664 |
| Ind-Swift Laboratories Limited | Sep 2026 | ▲ New position | +640 |
| Rubicon Research Limited | Sep 2026 | ▲ Increasing | +466 |
| Medico Remedies Limited | Sep 2026 | ▲ New position | +425 |
| Anthem Biosciences Limited | Sep 2026 | ▼ Reducing | -404 |
| Torrent Pharmaceuticals Limited | Sep 2026 | ▼ Reducing | -293 |
| Krishna Institute of Medical Sciences Limited | Sep 2026 | ▲ Increasing | +279 |
| Gaudium IVF and Women Health Limited | Sep 2026 | ▲ New position | +277 |
| Sun Pharmaceutical Industries Limited | Sep 2026 | ▲ Increasing | +268 |
| Park Medi World Limited | Sep 2026 | ▲ Increasing | +241 |
| Amrutanjan Health Care Limited | Sep 2026 | ▲ New position | +200 |
| Nephrocare Health Services Limited | Sep 2026 | ▲ Increasing | +192 |
| Max Healthcare Institute Limited | Sep 2026 | ▲ Increasing | +184 |
| CORONA Remedies Limited | Sep 2026 | ▲ Increasing | +170 |
| Laurus Labs Limited | Sep 2026 | ▲ Increasing | +170 |
| Piramal Pharma Limited | Sep 2026 | ▲ Increasing | +168 |
| Sai Parenterals Limited | Sep 2026 | ▲ New position | +157 |
| Kilitch Drugs (I) Ltd. | Sep 2026 | ▲ New position | +156 |
| Dr. Reddy's Laboratories Limited | Sep 2026 | ▲ Increasing | +151 |
| Aster DM Quality Care Limited | Sep 2026 | ▲ Increasing | +144 |
| Cipla Limited | Sep 2026 | ▲ Increasing | +141 |
| Fortis Healthcare Limited | Sep 2026 | ▲ Increasing | +130 |
| Syncom Formulations (India) Limited | Sep 2026 | ▲ Increasing | +114 |
| Eris Lifesciences Limited | Sep 2026 | ▼ Reducing | -112 |
| Emcure Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +108 |
| Medicamen Biotech Ltd. | Sep 2026 | ▲ New position | +100 |
| Venus Remedies Ltd. | Sep 2026 | ▲ New position | +100 |
| Health X Platform Limited | Sep 2026 | ▼ Complete exit | -98 |
| Viyash Scientific Limited | Sep 2026 | ▲ Increasing | +95 |
| Fredun Pharmaceuticals Limited | Sep 2026 | ▲ New position | +93 |
| Fischer Medical Ventures Limited | Sep 2026 | ▲ Increasing | +91 |
| Jupiter Life Line Hospitals Limited | Sep 2026 | ▲ Increasing | +90 |
| Morepen Laboratories Limited | Sep 2026 | ▲ Increasing | +86 |
| One Global Service Provider Limited | Sep 2026 | ▲ New position | +67 |
| Lupin Limited | Sep 2026 | ▲ Increasing | +60 |
| Sigachi Industries Limited | Sep 2026 | ▲ Increasing | +60 |
| Global Health Limited | Sep 2026 | ▲ Increasing | +56 |
| Marksans Pharma Limited | Sep 2026 | ▲ Increasing | +53 |
| Syngene International Limited | Sep 2026 | ▲ Increasing | +51 |
| Blue Jet Healthcare Limited | Sep 2026 | ▲ Increasing | +50 |
| Shree Ganesh Remedies Limited | Sep 2026 | ▼ Complete exit | -45 |
| Ajanta Pharma Limited | Sep 2026 | ▲ Increasing | +44 |
| Cohance Lifesciences Limited | Sep 2026 | ▲ Increasing | +40 |
| Glenmark Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +37 |
| Sai Life Sciences Limited | Sep 2026 | ▲ Increasing | +36 |
| Granules India Limited | Sep 2026 | ▲ Increasing | +36 |
| IPCA Laboratories Limited | Sep 2026 | ▲ Increasing | +35 |
| Aurobindo Pharma Limited | Sep 2026 | ▲ Increasing | +35 |
| Zydus Lifesciences Limited | Sep 2026 | ▲ Increasing | +34 |
| Divi's Laboratories Limited | Sep 2026 | ▲ Increasing | +32 |
| Shilpa Medicare Limited | Sep 2026 | ▲ Increasing | +29 |
| Mankind Pharma Limited | Sep 2026 | ▲ Increasing | +29 |
| Vijaya Diagnostic Centre Limited | Sep 2026 | ▲ Increasing | +27 |
| Fabtech Technologies Limited | Sep 2026 | ▲ Increasing | +26 |
| Solara Active Pharma Sciences Limited | Sep 2026 | ▲ Increasing | +26 |
| Indegene Limited | Sep 2026 | ▲ Increasing | +26 |
| Metropolis Healthcare Limited | Sep 2026 | ▲ Increasing | +26 |
| Apollo Hospitals Enterprise Limited | Sep 2026 | ▲ Increasing | +25 |
| Sun Pharma Advanced Research Company Limited | Sep 2026 | ▲ Increasing | +23 |
| Bliss GVS Pharma Limited | Sep 2026 | ▲ Increasing | +22 |
| NGL Fine-Chem Limited | Sep 2026 | ▲ New position | +22 |
| Aarti Drugs Limited | Sep 2026 | ▲ Increasing | +21 |
| Gland Pharma Limited | Sep 2026 | ▲ Increasing | +21 |
| Wockhardt Limited | Sep 2026 | ▲ Increasing | +21 |
| Dr. Lal Path Labs Ltd. | Sep 2026 | ▲ Increasing | +20 |
| Jubilant Pharmova Limited | Sep 2026 | ▲ Increasing | +20 |
| Suven Life Sciences Limited | Sep 2026 | ▲ Increasing | +19 |
| Dr. Agarwal's Health Care Limited | Sep 2026 | ▲ Increasing | +19 |
| Onesource Specialty Pharma Limited | Sep 2026 | ▲ Increasing | +19 |
| Narayana Hrudayalaya Ltd. | Sep 2026 | ▲ Increasing | +18 |
| Strides Pharma Science Limited | Sep 2026 | ▲ Increasing | +17 |
| Jagsonpal Pharmaceuticals Limited | Sep 2026 | ▼ Reducing | -17 |
| Dishman Carbogen Amcis Limited | Sep 2026 | ▲ Increasing | +16 |
| Thyrocare Technologies Limited | Sep 2026 | ▲ Increasing | +15 |
| Alkem Laboratories Limited | Sep 2026 | ▲ Increasing | +15 |
| Biocon Limited | Sep 2026 | ▲ Increasing | +14 |
| Alembic Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +14 |
| Healthcare Global Enterprises Limited | Sep 2026 | ▲ Increasing | +13 |
| Acutaas Chemicals Limited | Sep 2026 | ▲ Increasing | +13 |
| Bajaj Healthcare Limited | Sep 2026 | ▲ Increasing | +13 |
| Aarti Pharmalabs Limited | Sep 2026 | ▲ Increasing | +13 |
| FDC Limited | Sep 2026 | ▲ Increasing | +13 |
| Rainbow Childrens Medicare Limited | Sep 2026 | ▲ Increasing | +13 |
| Advanced Enzyme Technologies Limited | Sep 2026 | ▲ Increasing | +12 |
| Artemis Medicare Services Limited | Sep 2026 | ▲ Increasing | +12 |
| Indraprastha Medical Corporation Limited | Sep 2026 | ▲ Increasing | +11 |
| Yatharth Hospital & Trauma Care Services Limited | Sep 2026 | ▲ Increasing | +11 |
| K M C Speciality Hospitals (India) Limited | Sep 2026 | ▲ Increasing | +10 |
| Poly Medicure Limited | Sep 2026 | ▲ Increasing | +10 |
| GlaxoSmithKline Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +10 |
| IOL Chemicals and Pharmaceuticals Limited | Sep 2026 | ▼ Reducing | -10 |
| Concord Biotech Limited | Sep 2026 | ▲ Increasing | +9 |
| Indoco Remedies Limited | Sep 2026 | ▲ Increasing | +9 |
| Akums Drugs and Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +9 |
| Hikal Limited | Sep 2026 | ▲ Increasing | +9 |
Changes compare consecutive month-end disclosures for this portfolio only.